# KLOW Safe

> An evidence-led reading of what is — and is not — known about the four-peptide KLOW blend. Hover any claim to see its provenance.

## Pages

- [KLOW Safe — What we know and don't know about the four-peptide KLOW research blend](/index.md): KLOW combines GHK-Cu, BPC-157, TB-500, and KPV in one vial. No combination study has been published. Here is what the single-agent research actually shows.
- [KLOW reported effects and safety cautions](/effects.md): KLOW reported effects and safety cautions: what research-use communities describe (anecdotal, not clinical evidence), plus cited safety notes on WADA status, the cancer caution, and the untested combination.
- [KLOW Research Evidence — Component-by-Component Literature Summary](/research.md): What the published research actually shows for each of the four KLOW peptides: BPC-157 (rodent-dominated), GHK-Cu (topical human RCTs), TB-500 (largely full-length Tβ4 surrogate data), KPV (mouse colitis models). No combination study exists.
- [KLOW Safety Review — What Is and Is Not Known](/safety.md): Component-by-component safety review of the KLOW blend: what the rodent and human single-agent data show, what has never been studied in combination, manufacturing concerns, and regulatory status.
- [KLOW Dosage Research Context — What Has Been Studied in What Species](/dosage.md): Research-context dose ranges for each KLOW component as documented in the preclinical and limited clinical literature. No validated human dose. No combination dose-finding study.
- [KLOW FAQ — Common Questions About the Four-Peptide Research Blend](/faq.md): Direct answers to the most common questions about KLOW safety, components, regulatory status, and what the research literature actually shows.
- [KLOW References — Full Citation List with DOIs](/references.md): Complete list of peer-reviewed citations used across this site: 22 studies and regulatory documents covering BPC-157, GHK-Cu, TB-500 / full-length Tβ4, KPV, and the regulatory status of the KLOW components.
- [About KLOW Safe — Independent Editorial Project](/about.md): KLOW Safe is an independent editorial project that summarizes peer-reviewed research on the four-peptide KLOW blend. Not a clinic. Not a vendor. Editorial commentary on publicly available science.
- [Contact — KLOW Safe](/contact.md): Contact KLOW Safe for editorial corrections, citation suggestions, or questions about the methodology. We do not provide medical advice, dosing guidance, or vendor information.